Subject: Outstanding Bills for Work Performed
From: "Lisa Barclay" <[email-masked]>
To: "Goldman, Leslie J \(Retired Partner\)" <[email-masked]>, "Linda Powers" <[email-masked]>
Cc: "Hunter Biden" <[email-masked]>, "Hunter Biden" <[email-masked]>, "Lisa Barclay" <[email-masked]>
Date: Wed, 5 Jul 2017 11:46:12 -0400

Dear Les and Linda:

I hope this email finds you well.

I write seeking payment for the work that we at BSF performed for you to date.  The total outstanding amount is $15,729-I don't believe that we have received any payment at all from you thus far.  I have listed the dates and invoice numbers for the outstanding invoices below, and I can provide full copies if necessary.

Can you please remit payment as soon as possible, or at least respond to this email to let me know that you have received it?  I am sure that you can understand that I am receiving a lot of pressure from my managing partners to collect on all outstanding amounts as soon as possible.

Thank you very much,

Lisa

Northwest Biotherapeutics

FDA Issues

L. Barclay

DC

130562 (024560001)

$3,852

#######

$3,852.00

Northwest Biotherapeutics

FDA Issues

L. Barclay

DC

131976 (024560001)

$4,815

#######

$4,815.00

Northwest Biotherapeutics

FDA Issues

L. Barclay

DC

133158 (024560001)

$7,062

Apr 2016

$7,062.00

Lisa Barclay
Partner

BOIES SCHILLER FLEXNER LLP
1401 New York Avenue, NW
Washington, DC  20005
(t) 202.237.2727
(m) 202.744.1988
[email-masked]<mailto:[email-masked]>
www.bsfllp.com<http://www.bsfllp.com>

________________________________
The information contained in this electronic message is confidential information intended only for the use of the named recipient(s) and may contain information that, among other protections, is the subject of attorney-client privilege, attorney work product or exempt from disclosure under applicable law. If the reader of this electronic message is not the named recipient, or the employee or agent responsible to deliver it to the named recipient, you are hereby notified that any dissemination, distribution, copying or other use of this communication is strictly prohibited and no privilege is waived. If you have received this communication in error, please immediately notify the sender by replying to this electronic message and then deleting this electronic message from your computer. [v.1